AIRSUPRA 90 ug/1

AIRSUPRA 90 ug/1 combines albuterol sulfate and budesonide for respiratory conditions. This metered aerosol inhaler offers dual-action relief for breathing difficulties. Ideal for managing asthma and COPD symptoms.

AIRSUPRA 90 ug/1 is primarily used for the maintenance and relief of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The combination of albuterol sulfate, a bronchodilator, and budesonide, a corticosteroid, works to open airways and reduce inflammation. This inhaler is often prescribed for long-term management of breathing difficulties.

Users of AIRSUPRA 90 ug/1 may experience improved breathing and reduced wheezing. Common effects include relief from shortness of breath and a decrease in respiratory symptoms. Some users might notice mild side effects, but these typically subside as the body adjusts to the medication.

AIRSUPRA 90 ug/1 should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Users should be aware of potential side effects and consult their healthcare provider if any concerns arise. Proper storage and handling of the inhaler are essential to maintain its effectiveness.

AIRSUPRA 90 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other respiratory medications should be used with caution.